See LEGEND for key to shading and symbols.
:: Subject Area - OPTM Term - Semester 1
Data is correct as at Thu 6 Sep 19:04:45 AEST 2018
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
OPTM0001 | Research Thesis Optometry F/T | ||||||
THE | 0001 | 10211 | Enr | Open | 33/60 | 55% | |
OPTM0002 | Research Thesis Optometry P/T | ||||||
THE | 0001 | 10212 | Enr | Open | 8/60 | 13% | |
OPTM2133 | The Clinical Environment | ||||||
LAB | GP1 | 8987 | Rel | Open | 17/20 | 85% | Tue 09-11 (w2-5,6-7,9-11, Myers 2009); Tue 09-11 (w12-13, Myers 2009) |
LAB | GP2 | 8988 | Rel | Full | 22/22 | 100% | Tue 11-13 (w2-5,6-7,9-11, Myers 2009); Tue 11-13 (w12-13, Myers 2009) |
LAB | GP3 | 8989 | Rel | Open | 20/21 | 95% | Tue 15-17 (w2-5,6-7,9-11, Myers 2009); Tue 15-17 (w12-13, Myers 2009) |
LAB | GP4 | 8990 | Rel | Open | 23/24 | 96% | Wed 10-12 (w2-5,6-7,9-11, Myers 2009); Wed 10-12 (w12-13, Myers 2009) |
LAB | GP5 | 8991 | Rel | Stop | 23/24 | 96% | Fri 09-11 (w2-5,6-7,9-11, Myers 2009); Fri 09-11 (w12-13, Myers 2009) |
LAB | GP6 | 8992 | Rel | Open | 20/22 | 91% | Wed 12-14 (w2-5,6-7,9-11, Myers 2009); Wed 12-14 (w12-13, Myers 2009) |
LEC | A | 8999 | Rel | Open | 125/144 | 87% | Thu 09-12 (Myers 2030); Thu 12 (w1-4, ColomboThB); Thu 12 (w6-9,5, TETB G16); Thu 14 (w1, OMB149); Thu 14 (w2-5,6-12, OMB149); Thu 16 (w1-5,6, OMB149); Fri 15 (w1-4,6-9, OMB149) |
TUT | 001 | 8993 | Enr | Open | 18/20 | 90% | Tue 17 (w1-5,6-7,9-11, Quad G041) |
TUT | 002 | 8994 | Enr | Full | 22/22 | 100% | Wed 08 (w1-5,6-7,9-11, Quad G041) |
TUT | 003 | 8995 | Enr | Open | 19/20 | 95% | Tue 13 (w1-5,6-7,9-11, Quad G041) |
TUT | 004 | 8998 | Enr | Open | 23/24 | 96% | Thu 15 (w1-5,6-7,9-11, Quad G041) |
TUT | 005 | 8997 | Enr | Open | 23/24 | 96% | Thu 09 (w1-5,6-7,9-11, Quad G041) |
TUT | 006 | 8996 | Enr | Open | 20/22 | 91% | Thu 08 (w1-5,6-7,9-11, Quad G041) |
OPTM3111 | Optometry 3A | ||||||
LAB | GP1 | 5169 | Enr | Full | 24/24 | 100% | Thu 12-14 (w6, OMB G25); Thu 12-14 (w1, Myers 2009); Thu 12-14 (w2-5,8-13, Myers 2009); Thu 12-14 (w7, Myers 2009) |
LAB | GP2 | 5170 | Enr | Open | 22/23 | 96% | Thu 16-18 (w6, OMB G25); Thu 16-18 (w1, Myers 2009); Thu 16-18 (w2-5,8-13, Myers 2009); Thu 16-18 (w7, Myers 2009) |
LAB | GP3 | 5171 | Enr | Full | 24/24 | 100% | Fri 11-13 (w6, OMB G25); Fri 11-13 (w1, Myers 2009); Fri 11-13 (w2-5,8-13, Myers 2009); Fri 11-13 (w7, Myers 2009) |
LAB | GP4 | 5172 | Enr | Stop | 0/22 | 0% | Fri 14-16 (w6, OMB G25); Fri 14-16 (w1, Myers 2009); Fri 14-16 (w2-5,8-13, Myers 2009); Fri 14-16 (w7, Myers 2009) |
LEC | A | 5177 | Rel | Open | 70/83 | 84% | Mon 14 (w1-4, Law Th G23); Tue 12 (w1-3, TETB LG07); Wed 16 (w1-4,5,7-11, TETB LG03); Wed 16 (w6,12, TETB LG03); Thu 10-12 (w1-5,7, ChemSc M18); Thu 10-12 (w6,8-9,10,11-12, ChemSc M18) |
TUT | 001 | 5173 | Rel | Full | 24/24 | 100% | Thu 16-18 (w8, Sqhouse218) |
TUT | 002 | 5174 | Rel | Open | 22/23 | 96% | Fri 14-16 (w8, Sqhouse218) |
TUT | 003 | 5175 | Rel | Full | 24/24 | 100% | Fri 09-11 (w8, Gold G01) |
TUT | 004 | 5176 | Rel | Stop | 0/22 | 0% | Fri 11-13 (w8, Sqhouse218) |
OPTM3131 | Ocular Disease 3A | ||||||
LEC | A | 5179 | Rel | Open | 69/84 | 82% | Mon 11 (TETB LG07); Tue 09-11 (Law Th G23); Wed 13-15 (TETB LG03) |
TUT | 501 | 5178 | Enr | Open | 69/84 | 82% | Wed 09-12 (w4,7,11, Mat 103) |
OPTM4131 | Clinical Optometry 4A | ||||||
LEC | 001 | 10399 | Enr | Open | 67/105 | 64% | |
OPTM4151 | Ocular Therapeutics 4A | ||||||
LEC | 100 | 10400 | Enr | Open | 69/105 | 66% | |
OPTM5111 | Clinical Optometry 5A | ||||||
LEC | 001 | 10051 | Enr | Full* | 14/14 | 100% | |
OPTM5131 | Specialist Clinical Optom 5A | ||||||
LEC | 001 | 10052 | Enr | Full* | 13/13 | 100% | |
OPTM5151 | Clinical Ocular Therap 5A | ||||||
CLN | 001 | 10053 | Enr | Full* | 14/14 | 100% | |
OPTM5171 | Research Project 5A | ||||||
LEC | 001 | 10054 | Enr | Open* | 1/5 | 20% | |
OPTM6411 | Contact Lenses | ||||||
LAB | 501 | 9009 | Enr | Open | 4/9 | 44% | Mon 11-13 (w2-5,6-13, Myers 2009) |
LAB | 502 | 9010 | Enr | Open | 15/22 | 68% | Mon 13-15 (w2-5,6-13, Myers 2009) |
LAB | 503 | 9011 | Enr | Open | 15/22 | 68% | Mon 15-17 (w2-5,6-13, Myers 2009) |
LAB | 504 | 9012 | Enr | Full | 22/22 | 100% | Wed 16-18 (w2-5,6-13, Myers 2009) |
LAB | 505 | 9013 | Enr | Open | 20/22 | 91% | Thu 14-16 (w2-5,6-13, Myers 2009) |
LAB | 506 | 9014 | Enr | Tent | 0/22 | 0% | Wed 14-16 (w2-5,6-13, Myers 2009) |
LEC | A | 9015 | Rel | Open | 76/111 | 68% | Tue 15-17 (w1-5,6,8,10-11, OMB G31); Tue 15-17 (w7, OMB G31); Tue 15-17 (w9, OMB G31); Tue 15-17 (w12-13, OMB G31) |
OPTM6412 | Clinical Optometry 4A | ||||||
LEC | F10A | 9016 | Enr | Full* | 8/8 | 100% | Mon 17 (w2-5,6-13, ColomboThC); Fri 10 (w2-5,6-13, Myers Thtr) |
OPTM6413 | Anterior Eye Therapeutics | ||||||
LAB | 501 | 9000 | Enr | Full* | 1/1 | 100% | Tue 11-13 (w8-12, OPTM CL) |
LAB | 502 | 9001 | Enr | Full* | 1/1 | 100% | Tue 13-15 (w8-12, OPTM CL) |
LAB | 503 | 9002 | Enr | Tent* | 0/4 | 0% | Fri 11-13 (w8-12, OPTM CL) |
LAB | 504 | 9003 | Enr | Full* | 1/1 | 100% | Fri 13-15 (w8-12, OPTM CL) |
LAB | 505 | 9004 | Enr | Full* | 1/1 | 100% | Mon 13-15 (w8-12, OPTM CL) |
LEC | A | 9007 | Rel | Full* | 4/4 | 100% | Fri 08-10 (w6-13, Myers Thtr) |
TUT | 506 | 9005 | Rel | Full* | 4/4 | 100% | Mon 09-11 (w2-5,6-7, Mat 103) |
TUT | 507 | 9006 | Rel | Tent* | 0/1 | 0% | Fri 11-13 (w2-5,6-7, Gold G07) |
OPTM7001 | Intro to Community Eye Health | ||||||
LEC | 001 | 10850 | Enr | Open | 13/20 | 65% | |
OPTM7108 | Research Skills in Optometry | ||||||
LEC | 001 | 10848 | Enr | Open | 1/30 | 3% | |
OPTM7115 | Visual Neuroscience | ||||||
LEC | 001 | 10853 | Enr | Canc | 0/0 | N/A | |
OPTM7117 | Ocular Therapy 2 | ||||||
LEC | 001 | 10970 | Enr | Open | 1/30 | 3% | |
OPTM7205 | Specialty Contact Lens Studies | ||||||
LEC | 001 | 10852 | Enr | Open | 5/20 | 25% | |
OPTM7213 | Ocular Therapy | ||||||
LEC | 001 | 10397 | Enr | Open | 49/50 | 98% | |
OPTM7301 | Advanced Clinical Optometry | ||||||
LEC | 001 | 11004 | Enr | Open | 1/30 | 3% | |
OPTM7302 | Evidence Based Optometry | ||||||
LEC | 001 | 10847 | Enr | Open | 10/20 | 50% | |
OPTM7308 | Research Project | ||||||
LEC | 001 | 10849 | Enr | Open | 11/30 | 37% | |
OPTM7511 | Advanced Ocular Disease 1 | ||||||
LEC | 001 | 10851 | Enr | Open | 14/20 | 70% | |
OPTM7521 | Advanced Ocular Disease 2 | ||||||
LEC | 001 | 11217 | Enr | Open | 9/12 | 75% | |
OPTM8511 | Clinical Paeds, LV and CV | ||||||
TUT | 501 | 9008 | Enr | Open | 73/94 | 78% | Tue 15:30 (Myers Thtr) |
OPTM8512 | Clinical Optometry 5A | ||||||
LEC | A | 9017 | Enr | Open | 73/94 | 78% | Fri 13 (Myers Thtr) |
OPTM8513 | Clinical Ocular Therapy 5A | ||||||
CLN | 001 | 10045 | Enr | Open | 73/94 | 78% | |
OPTM8518 | Research Project A | ||||||
OTH | 001 | 10044 | Enr | Open | 77/94 | 82% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |